|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed maturities, available for sale, at fair value (Amortized cost 2026: $13,916,563; 2025: $12,937,728 Allowance for expected credit losses 2026: $1,898; 2025: $1,836) | ||||||||||||||||||||
| Fixed maturities, held to maturity, at amortized cost (Fair value 2026: $402,105; 2025: $395,942 Allowance for expected credit losses 2026: $nil; 2025: $nil) | ||||||||||||||||||||
| Equity securities, at fair value (Cost 2025: $534,096; 2024: $520,743) | ||||||||||||||||||||
| Equity securities, at fair value (Cost 2026: $606,505; 2025: $581,275) | ||||||||||||||||||||
| Mortgage loans, held for investment, at fair value (Allowance for expected credit losses 2026: $27,957; 2025: $29,742) | ||||||||||||||||||||
| Other investments, at fair value | ||||||||||||||||||||
| Equity method investments | ||||||||||||||||||||
| Short-term investments, at fair value | ||||||||||||||||||||
| Total investments | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash and cash equivalents | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Insurance and reinsurance premium balances receivable (Allowance for expected credit losses 2026: $14,479; 2025: $15,821) | ||||||||||||||||||||
| Reinsurance recoverable on unpaid losses and loss expenses (Allowance for expected credit losses 2026: $41,354; 2025: $40,340) | ||||||||||||||||||||
| Reinsurance recoverable on paid losses and loss expenses | ||||||||||||||||||||
| Deferred acquisition costs | ||||||||||||||||||||
| Prepaid reinsurance premiums | ||||||||||||||||||||
| Receivable for investments sold | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets | ||||||||||||||||||||
| Operating lease right-of-use assets | ||||||||||||||||||||
| Loan advances made | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Reserve for losses and loss expenses | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Insurance and reinsurance balances payable | ||||||||||||||||||||
| Debt | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Payable for investments purchased | ||||||||||||||||||||
| Operating lease liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity | ||||||||||||||||||||
| Preferred shares | ||||||||||||||||||||
| Common shares (shares issued 2026: 176,580; 2025: 176,580 shares outstanding 2026: 73,141; 2025: 74,135) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury shares, at cost (2026: 103,439; 2025: 102,445) | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
